Key Message
The novelty and strength of our study were to show the efficacy and
perceived satisfaction of 3-year SLIT via a real-life design.
Despite the presence of robust evidence, very sparse data are available
on the efficacy and perceived satisfaction of SLIT on selected patients
inĀ real-life . We strongly believe that real-world studies,
using data collected in everyday clinical settings, can hold the promise
of providing real data to maximize the applicability and
generalizability of an intervention. Moreover, the possibility to
collect and test everything, and not only data-driven, will give the
chance to realize a model analyzing both internal andexternal data sources and understand the context and patient
behaviour. Furthermore, it becomes crucial especially in the drug
approval process. All these fine-grained health data will open the way
for personalized medicine to satisfy the unmet needs of a broad range of
patients who reflect the diversity of persons and not only those who
volunteer for clinical trials or biobanks.